fluconazole and tavaborole

fluconazole has been researched along with tavaborole in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rosen, T; Stein Gold, LF	1
Lipner, SR; Scher, RK	1

Reviews

1 review(s) available for fluconazole and tavaborole

Article	Year
Onychomycosis: Treatment and prevention of recurrence. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles	2019

Article

Year

Onychomycosis: Treatment and prevention of recurrence.

Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles

2019

Other Studies

1 other study(ies) available for fluconazole and tavaborole

Article	Year
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action. Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3 Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States	2016

Article

Year

Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.

Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States

2016